Piper Jaffray analyst Tyler Van ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst PT Change

Adverum Biotechnologies (ADVM) PT Lowered to $4.50 at Chardan Capital MarketsNovember 2, 2018 9:05 AM SunTrust Robinson Humphrey Downgrades Adverum Biotechnologies (ADVM) to HoldNovember 2, 2018 6:23 AM Raymond James Downgrades Adverum Biotechnologies (ADVM) to Market PerformNovember 2, 2018 5:10 AM